348 related articles for article (PubMed ID: 21762074)
1. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
2. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
3. Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications.
Gajate C; Mollinedo F
J Leukoc Biol; 2015 Nov; 98(5):739-59. PubMed ID: 26246489
[TBL] [Abstract][Full Text] [Related]
4. Lipid raft connection between extrinsic and intrinsic apoptotic pathways.
Gajate C; Gonzalez-Camacho F; Mollinedo F
Biochem Biophys Res Commun; 2009 Mar; 380(4):780-4. PubMed ID: 19338752
[TBL] [Abstract][Full Text] [Related]
5. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
6. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Gajate C; Gonzalez-Camacho F; Mollinedo F
PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
[TBL] [Abstract][Full Text] [Related]
7. CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells.
Eramo A; Sargiacomo M; Ricci-Vitiani L; Todaro M; Stassi G; Messina CG; Parolini I; Lotti F; Sette G; Peschle C; De Maria R
Eur J Immunol; 2004 Jul; 34(7):1930-40. PubMed ID: 15214041
[TBL] [Abstract][Full Text] [Related]
8. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
9. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
Reis-Sobreiro M; Gajate C; Mollinedo F
Oncogene; 2009 Sep; 28(36):3221-34. PubMed ID: 19561642
[TBL] [Abstract][Full Text] [Related]
10. Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.
Gajate C; Mollinedo F
Apoptosis; 2015 May; 20(5):584-606. PubMed ID: 25702154
[TBL] [Abstract][Full Text] [Related]
11. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
Gajate C; Mollinedo F
Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375
[TBL] [Abstract][Full Text] [Related]
12. Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.
Bénéteau M; Pizon M; Chaigne-Delalande B; Daburon S; Moreau P; De Giorgi F; Ichas F; Rebillard A; Dimanche-Boitrel MT; Taupin JL; Moreau JF; Legembre P
Mol Cancer Res; 2008 Apr; 6(4):604-13. PubMed ID: 18403639
[TBL] [Abstract][Full Text] [Related]
13. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
Lacour S; Hammann A; Grazide S; Lagadic-Gossmann D; Athias A; Sergent O; Laurent G; Gambert P; Solary E; Dimanche-Boitrel MT
Cancer Res; 2004 May; 64(10):3593-8. PubMed ID: 15150117
[TBL] [Abstract][Full Text] [Related]
15. Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis.
Gniadecki R
Biochem Biophys Res Commun; 2004 Jul; 320(1):165-9. PubMed ID: 15207716
[TBL] [Abstract][Full Text] [Related]
16. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
Muppidi JR; Siegel RM
Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
[TBL] [Abstract][Full Text] [Related]
17. Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment.
Legembre P; Daburon S; Moreau P; Ichas F; de Giorgi F; Moreau JF; Taupin JL
Mol Cell Biol; 2005 Aug; 25(15):6811-20. PubMed ID: 16024813
[TBL] [Abstract][Full Text] [Related]
18. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
19. Clusters of apoptotic signaling molecule-enriched rafts, CASMERs: membrane platforms for protein assembly in Fas/CD95 signaling and targets in cancer therapy.
Mollinedo F; Gajate C
Biochem Soc Trans; 2022 Jun; 50(3):1105-1118. PubMed ID: 35587168
[TBL] [Abstract][Full Text] [Related]
20. The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability.
Henkler F; Behrle E; Dennehy KM; Wicovsky A; Peters N; Warnke C; Pfizenmaier K; Wajant H
J Cell Biol; 2005 Mar; 168(7):1087-98. PubMed ID: 15795317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
